Takara Bio Inc.
Investor Relations
Financial Data
Financial Highlights（Quarterly）

Financial Highlights（Quarterly）

Financial Highlights（Quarterly）

Net Sales

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	34,565	46,086	67,699	78,142	43,505	-
3Q	24,558	29,549	45,659	60,206	29,734	-
2Q	16,450	17,393	31,551	32,587	19,116	-
1Q	8,650	6,938	15,272	14,102	9,176	8,493

Operating Income

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	6,274	13,952	28,902	20,541	3,003	-
3Q	3,879	8,791	19,926	19,403	336	-
2Q	3,035	3,736	14,105	10,870	1,410	-
1Q	2,251	693	8,504	4,537	423	-1,634

Ordinary Income

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	6,347	14,159	28,459	20,682	3,405	-
3Q	3,896	8,919	20,154	19,480	586	-
2Q	2,961	3,820	14,241	10,955	1,598	-
1Q	2,200	745	8,579	4,593	509	-1,498

Profit Attributable to Owners of Parent

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	3,819	9,547	19,849	16,012	1,480	-
3Q	2,708	5,726	14,364	14,595	154	-
2Q	2,075	2,274	10,009	8,538	1,084	-
1Q	1,591	404	6,025	3,907	319	-1,047

Net Income Per Share

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	31.72	79.29	164.84	132.97	12.30	-
3Q	22.49	47.56	119.29	121.21	1.28	-
2Q	17.23	18.89	83.12	70.91	9.00	-
1Q	13.22	3.36	50.04	32.45	2.65	-8.70

Total Assets

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	75,009	89,750	115,712	129,202	121,252	-
3Q	71,835	83,846	106,116	128,140	123,087	-
2Q	70,837	77,343	104,777	120,023	123,283	-
1Q	71,402	73,593	99,658	111,488	120,662	121,752

Net Assets

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	66,591	74,302	96,064	112,454	111,784	-
3Q	64,888	70,568	89,455	114,711	112,529	-
2Q	64,558	67,236	84,766	106,949	112,130	-
1Q	65,154	65,580	80,586	98,425	108,207	111,516

Capital Adequacy Ratio

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	88.7	82.7	82.9	86.9	92.0	-
3Q	90.2	84.0	84.1	89.3	91.2	-
2Q	91.0	86.8	80.7	88.9	90.7	-
1Q	91.1	89.0	80.7	88.1	89.5	91.3

CLOSE
MENU

サイト内検索

footer-content

menu

JA
EN

contact

gnavi-box